/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

F

Frank Perabo

Io Therapeutics (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

101

Papers

5.0K

Citations

26

h-index

39

i10-index

Frank Perabo is an academic researcher from Io Therapeutics (United States). The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer, Lipids, and Metabolism & Epigenetics and DNA Methylation. The author has an h-index of 26, co-authored 86 publications.

Research Topics

Prostate Cancer Treatment and Research Cancer, Lipids, and Metabolism Epigenetics and DNA Methylation Radiopharmaceutical Chemistry and Applications Bladder and Urothelial Cancer Treatments

Papers by this author

works

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

2014 · New England Journal of Medicine · 3,004 citations

https://doi.org/10.1056/nejmoa1405095

Tomasz M. Beer Andrew J. Armstrong Dana E. Rathkopf Yohann Loriot

Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results

2015 · European Urology · 45 citations

https://doi.org/10.1016/j.eururo.2015.01.027

Bertrand Tombal Michael Borre Per Rathenborg Patrick Werbrouck

Research topics

topics

Prostate Cancer Treatment and Research

Cancer, Lipids, and Metabolism

Epigenetics and DNA Methylation

Radiopharmaceutical Chemistry and Applications

Bladder and Urothelial Cancer Treatments

Chat about Author

Papers

Chat

Click to start Chat